In another approach to find a treatment for AHP, gene therapy with a viral vector delivering a normal hydroxymethylbilane synthase (HMBS) gene to hepatocytes was assessed in a Phase I clinical trial. This evidence concerns the gene HMBS and anhaptoglobinemia.